Bandoh K, Aoki J, Hosono H, Kobayashi S, Kobayashi T, Murakami-Murofushi K, Tsujimoto M, Arai H, Inoue K
Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
J Biol Chem. 1999 Sep 24;274(39):27776-85. doi: 10.1074/jbc.274.39.27776.
Lysophosphatidic acid (LPA), together with sphingosine 1-phosphate, is a bioactive lipid mediator that acts on G-protein-coupled receptors to evoke multiple cellular responses, including Ca(2+) mobilization, modulation of adenylyl cyclase, and mitogen-activated protein (MAP) kinase activation. In this study, we isolated a human cDNA encoding a novel G-protein-coupled receptor, designated EDG7, and characterized it as a cellular receptor for LPA. The amino acid sequence of the EDG7 protein is 53.7 and 48.8% identical to those of the human functional LPA receptors EDG2 and EDG4, respectively, previously identified. LPA (oleoyl) but not other lysophospholipids induced an increase in the Ca(2+) of EDG7-overexpressing Sf9 cells. Other LPA receptors, EDG4 but not EDG2, transduced the Ca(2+) response by LPA when expressed in Sf9 cells. LPAs with an unsaturated fatty acid but not with a saturated fatty acid induced an increase in the Ca(2+) of EDG7-expressing Sf9 cells, whereas LPAs with both saturated and unsaturated fatty acids elicited a Ca(2+) response in Sf9 cells expressing EDG4. In EDG7- or EDG4-expressing Sf9 cells, LPA stimulated forskolin-induced increase in intracellular cAMP levels, which was not observed in EDG2-expressing cells. In PC12 cells, EDG4 but not EDG2 or EDG7 mediated the activation of MAP kinase by LPA. Neither the EDG7- nor EDG4-transduced Ca(2+) response or cAMP accumulation was inhibited by pertussis toxin. In conclusion, the present study demonstrates that EDG7, a new member of the EDG family of G-protein-coupled receptors, is a specific LPA receptor that shows distinct properties from known cloned LPA receptors in ligand specificities, Ca(2+) response, modulation of adenylyl cyclase, and MAP kinase activation.
溶血磷脂酸(LPA)与1-磷酸鞘氨醇一样,是一种生物活性脂质介质,作用于G蛋白偶联受体,引发多种细胞反应,包括钙离子动员、腺苷酸环化酶调节和丝裂原活化蛋白(MAP)激酶激活。在本研究中,我们分离出一种编码新型G蛋白偶联受体的人类cDNA,命名为EDG7,并将其鉴定为LPA的细胞受体。EDG7蛋白的氨基酸序列与先前鉴定的人类功能性LPA受体EDG2和EDG4的氨基酸序列分别具有53.7%和48.8%的同一性。LPA(油酰基)而非其他溶血磷脂能诱导过表达EDG7的Sf9细胞内钙离子浓度升高。其他LPA受体,即EDG4而非EDG2,在Sf9细胞中表达时能转导LPA引起的钙离子反应。含有不饱和脂肪酸而非饱和脂肪酸的LPA能诱导表达EDG7的Sf9细胞内钙离子浓度升高,而同时含有饱和脂肪酸和不饱和脂肪酸的LPA能在表达EDG4的Sf9细胞中引发钙离子反应。在表达EDG7或EDG4的Sf9细胞中,LPA刺激了福斯高林诱导的细胞内cAMP水平升高,而在表达EDG2的细胞中未观察到这种现象。在PC12细胞中,EDG4而非EDG2或EDG7介导了LPA对MAP激酶的激活。百日咳毒素既不抑制EDG7也不抑制EDG4转导的钙离子反应或cAMP积累。总之,本研究表明,G蛋白偶联受体EDG家族的新成员EDG7是一种特异性LPA受体,在配体特异性、钙离子反应、腺苷酸环化酶调节和MAP激酶激活方面表现出与已知克隆的LPA受体不同的特性。